Polydextrose for the prevention and/or treatment of heart failure
AssigneesVaiomer, Institut National De La Sante Et De La Recherche Medicale (Inserm)
InventorsChristophe Heymes, Rémy Burcelin, Benjamin Lelouvier, Jacques Amar
Life of this patent
Estimating the term…
Abstract
A method is provided for preventing and/or treating heart failure in a subject in need thereof by administering to the subject a therapeutically effective amount of polydextrose. The method may also include the use of polydextrose for preventing cardiac remodeling and/or ventricle dilatation and/or for preventing systolic dysfunction, as well as preventing an increase in bacterial translocation to heart tissue in a subject who suffered from a myocardial infarction.
Claims16
A method for preventing and/or treating heart failure in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a pharmaceutical composition consisting of polydextrose and one or more excipients, wherein said subject suffered from a myocardial infarction.
A method for preventing and/or treating heart failure in a subject in need thereof, comprising administering to said subject a therapeutically effective amount of a pharmaceutical composition consisting of polydextrose and one or more excipients, wherein said subject suffered from a myocardial infarction, and wherein polydextrose is administered to said subject after myocardial infarction occurred.
Dependencies are inferred from the claim text.